Niaspan inhibits diabetic retinopathy-induced vascular inflammation by downregulating the tumor necrosis factor-α pathway

Diabetic retinopathy (DR) is a serious microvascular complication of diabetes and a major cause of blindness in the developing world. Early DR is characterized by vascular neuroinflammation, cell apoptosis and breakdown of the blood-retinal barrier (BRB). However, optimal treatment options and assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Meng, Xiangda, Yan, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367335/
https://www.ncbi.nlm.nih.gov/pubmed/28138697
http://dx.doi.org/10.3892/mmr.2017.6146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367335/
https://www.ncbi.nlm.nih.gov/pubmed/28138697
http://dx.doi.org/10.3892/mmr.2017.6146

Ejemplares similares